Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol
In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire
Interactive R01 Scores Vary widely, Result Of separate Review
Fisher, Bonadonna, Croce, Hanafusa Win GAM Cancer Prizes
ASCO Honors Holland, Koop, Monaco With Special Awards
ONS To Fund 21 Grants In ’94 Deadline Dec. 1
Prevention & Control Study Section Needed: Letter to the Editor
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
